Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Umbilical cord blood platelet-rich plasma (CB-PRP) is a biologic product derived from the processed blood of human umbilical cords. It is prepared by centrifuging whole cord blood to concentrate platelets within the plasma fraction. CB-PRP contains high levels of growth factors (such as PDGF, bFGF, EGF, VEGF, TGFβ), cytokines, and other bioactive molecules including albumin and fibronectin. These components contribute to its regenerative and anti-inflammatory properties by promoting angiogenesis, cell proliferation and differentiation, tissue repair, and modulating immune responses. Compared to autologous PRP (A-PRP) from adult peripheral blood, CB-PRP typically has higher concentrations of growth factors and anti-inflammatory molecules[2][3][6][7]. CB-PRP is being investigated for use in regenerative medicine across multiple fields including orthopedics (e.g., osteoarthritis), dermatology (wound healing), neurology (spinal cord injury repair), ophthalmology (corneal ulcers/dry eye disease), obstetrics/gynecology (cesarean section wound healing), among others[2][6][7][8]. Its mechanism involves delivering trophic factors that stimulate local tissue regeneration when applied topically or injected into target tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on umbilical cord blood platelet-rich plasma.